February 26, 2015 6:51 PM ET

Biotechnology

Company Overview of CuraGen Corporation

Company Overview

CuraGen Corporation, a biopharmaceutical development company, develops novel therapeutics for the treatment of cancer in the United States and Europe. The company focuses on the development of CR011-vcMMAE, a Phase II clinical trail drug for the treatment of patients with metastatic melanoma and breast cancer. It has strategic collaborations with Amgen Fremont to develop fully-human monoclonal antibody therapeutics; and Seattle Genetics, Inc. to license Seattle Genetics’ proprietary antibody- drug conjugate technology. The company was founded in 1991 and is headquartered in Branford, Connecticut. As of October 1, 2009, CuraGen Corporation operates as a subsidiary of Celldex Therapeutics, Inc...

322 East Main Street

Branford, CT 06405

United States

Founded in 1991

16 Employees

Phone:

203-481-1104

Fax:

203-483-2552

Key Executives for CuraGen Corporation

Chief Financial Officer
Age: 66
Director of Investor Relations
Vice President of Medical Development
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
TVAX Animal Health, LLC United States
Regulon Inc. United States
Martek Biosciences Boulder Corporation United States
Kala Pharmaceuticals, Inc. United States
JH Biotech, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CuraGen Corporation, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.